IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q3 2018 Holdings

Filed 2018-11-01 | 54 holdings | $2.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Axogen Inc(AXGN)COM05463X106$369.0K10,00014.6%
Arvinas Inc(ARVN)COM04335A105$506.0K30,00020.0%
Corcept Therapeutics Inc(CORT)COM218352102$701.0K50,00027.7%
Biogen Inc(BIIB)COM09062X103$707.0K2,00027.9%
PreviousPage 2 of 2